Literature DB >> 34203247

The V-ATPase a3 Subunit: Structure, Function and Therapeutic Potential of an Essential Biomolecule in Osteoclastic Bone Resorption.

Anh Chu1, Ralph A Zirngibl1, Morris F Manolson1.   

Abstract

This review focuses on one of the 16 proteins composing the V-ATPase complex responsible for resorbing bone: the a3 subunit. The rationale for focusing on this biomolecule is that mutations in this one protein account for over 50% of osteopetrosis cases, highlighting its critical role in bone physiology. Despite its essential role in bone remodeling and its involvement in bone diseases, little is known about the way in which this subunit is targeted and regulated within osteoclasts. To this end, this review is broadened to include the three other mammalian paralogues (a1, a2 and a4) and the two yeast orthologs (Vph1p and Stv1p). By examining the literature on all of the paralogues/orthologs of the V-ATPase a subunit, we hope to provide insight into the molecular mechanisms and future research directions specific to a3. This review starts with an overview on bone, highlighting the role of V-ATPases in osteoclastic bone resorption. We then cover V-ATPases in other location/functions, highlighting the roles which the four mammalian a subunit paralogues might play in differential targeting and/or regulation. We review the ways in which the energy of ATP hydrolysis is converted into proton translocation, and go in depth into the diverse role of the a subunit, not only in proton translocation but also in lipid binding, cell signaling and human diseases. Finally, the therapeutic implication of targeting a3 specifically for bone diseases and cancer is discussed, with concluding remarks on future directions.

Entities:  

Keywords:  ATP6V0A3; ATP6V1C; OC-116 kDa; TCIRG1; V-ATPase; V-type proton ATPase 116 kDa subunit a3; anti-resorptive therapeutics; bone; osteoclasts; osteopetrosis; osteoporosis; signalosome

Year:  2021        PMID: 34203247     DOI: 10.3390/ijms22136934

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  4 in total

1.  The lysosomal V-ATPase a3 subunit is involved in localization of Mon1-Ccz1, the GEF for Rab7, to secretory lysosomes in osteoclasts.

Authors:  Naomi Matsumoto; Mizuki Sekiya; Ge-Hong Sun-Wada; Yoh Wada; Mayumi Nakanishi-Matsui
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

Review 2.  The V-ATPases in cancer and cell death.

Authors:  Fangquan Chen; Rui Kang; Jiao Liu; Daolin Tang
Journal:  Cancer Gene Ther       Date:  2022-05-03       Impact factor: 5.854

3.  Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations.

Authors:  Chunxiao Qi; Lei Lei; Jinqu Hu; Gang Wang; Jiyuan Liu; Shaowu Ou
Journal:  Cell Cycle       Date:  2022-03-10       Impact factor: 5.173

4.  Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma.

Authors:  Chao Xu; Bolin Jia; Zhan Yang; Zhenwei Han; Zhu Wang; Wuyao Liu; Yilong Cao; Yao Chen; Junfei Gu; Yong Zhang
Journal:  Cancers (Basel)       Date:  2022-09-21       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.